US Patent Issued to CHUGAI SEIYAKU on Aug. 5 for "Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,143, issued on Aug. 5, was assigned to CHUGAI SEIYAKU K.K. (Tokyo).

"Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion" was invented by Tomoyuki Igawa (Shizuoka, Japan), Naoka Hironiwa (Shizuoka, Japan) and Hiroki Kawauchi (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A multiple antigen-binding molecule fusion molecule containing a multiple antigen-binding molecule (Alpha) having an immune cell antigen-binding region and a cancer antigen-binding region, a cancer tissue-specific protease-cleavable linker (Bet...